The company has three facilities in Sweden and the UK serving customers in the pharmaceutical and biotech industries around the world.
Cobra offers integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze